PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsPharyngitis
MeSH D010612 - pharyngitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012141:Respiratory tract infections
$
Success rate
D010608:Pharyngeal diseases
0 Companies
0 Drugs
Success rate
D010612: 
Pharyngitis
D009304:Nasopharyngitis
0 Companies
0 Drugs
Success rate
D014069:Tonsillitis
D017703:Retropharyngeal abscess
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCefadroxil Cefadroxil  1989-02-10   
Cefprozil Cefprozil  2005-12-06   
Cefuroxime Cefuroxime  1998-04-16   
Cephalexin Cephalexin  1982-01-01   
PerrigoDextromethorphan, Guaifenesin Guaifenesin Dextromethorphan  2018-03-05   
Pseudoephedrine, Guaifenesin Guaifenesin Pseudoephedrine  2022-02-01   
GSKCefuroxime axetil Ceftin  1987-12-28   
Lupin ResearchCefadroxil Cefadroxil  2007-05-29   
Cefprozil Cefprozil  2005-12-19   
Cefuroxime axetil Cefuroxime Axetil  2003-07-25   
Cephalexin Cephalexin  2005-11-25   
SandozCefadroxil Cefadroxil  1982-01-01   
Cefprozil Cefprozil  2005-12-08   
Chartwell PharmaceuticalsCefadroxil Cefadroxil  2006-09-18   
Cefprozil Cefprozil  2005-11-14   
Cephalexin Cephalexin  2005-02-24   
Pseudoephedrine, Hydrocodone, Guaifenesin Hycofenix  2015-05-14   
Cefuroxime axetil Cefuroxime Axetil  2005-07-29   
SanofiTelithromycin Ketek  2001-07-09   
Telithromycin Levviax  2001-07-09   
Eli LillyCephalexin Keflet  1986-12-01   
Cephalexin Keftab  1987-10-29   
Cefuroxime Kefurox  1986-01-10   
Aurobindo PharmaCefadroxil Cefadroxil  2013-04-25   
Cefprozil Cefprozil  2007-05-24   
Cefuroxime axetil Cefuroxime Axetil  2006-03-29   
Cephalexin Cephalexin  2005-11-16   
Dextromethorphan, Guaifenesin Guaifenesin Dextromethorphan  2017-03-17   
Pseudoephedrine, Guaifenesin Guaifenesin Pseudoephedrine  2020-03-25   
Barr PharmaceuticalsCephalexin Cephalexin  1987-06-26   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
67%
6/9
Phase 3
65%
26/40
Approved: 10Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Allergan
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use